The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients

Pediatric Transplantation

Volumn 13, Issue 7, 2009, Pages 851-855

  Ben Youssef, Ramzi ^a   Baron, Pedro W ^a   Sahney, Shobha ^a   Weissman, Jill ^a   Baqai, Waheed ^a   Franco, Edson ^a   Kore, Arputharaj ^a   Trimzi, Mateen ^a   Ojogho, Okechukwu ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute rejection; Epstein Barr virus infections; Immune responses; Pediatric kidney transplantation; Therapeutic drug monitoring

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHYTOHEMAGGLUTININ;

ADOLESCENT; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNE FUNCTION TEST; KIDNEY TRANSPLANTATION; MALE; PEDIATRIC SURGERY; POSTOPERATIVE INFECTION; VIREMIA; VIRUS INFECTION;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349967823     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01073.x     Document Type: Article

References (22)

1. Hariharan S. Recommendations for outpatient monitoring of kidney transplant recipients. Am J Kidney Dis 2006 : 47 (4 Suppl. 2 S22 S36 (Review).
2. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 2004 : 4 : 384 389.
3. Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007 : 11 : 187 195.
4. Srinivas TR, Meier-Kriesche HU. Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol 2008 : 3 (Suppl. 2 S101 S116.
5. Visner GA, Goldfarb SB. Posttransplant monitoring of pediatric lung transplant recipients. Curr Opin Pediatr 2007 : 19 : 321 326.
6. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003 : 17 : 77 88.
7. Haddou T, Andre JL, Bourquard R, et al. Long-term follow-up of Epstein-Barr virus viremia in pediatric recipients of renal transplants. Pediatr Nephrol 2005 : 20 : 76 80.
8. Lee TC, Goss JA, Rooney CM, et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 2006 : 20 : 689 694.
9. Gautam A, Morissey PE, Brem AS, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006 : 10 : 613 616.
10. Hricik DE, Heeger PS. Minimization of immunosuppression in kidney transplantation. The need for immune monitoring. Transplantation 2001 : 72 (Suppl. S32 S35.
11. Grimm P. Use of an immune function assay to monitor immunosuppression. Pediatr Transplant 2006 : 10 : 533 535.
12. Israeli M, Yussim A, Mor E, Sredni B, Klein T. Preceeding the rejection: In search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007 : 18 : 7 12.
13. Kahan BD, Keown P, Levy GA, Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 2002 : 24 : 330 350 (Discussion 329).
14. Kyllonen LE, Salmela KT. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: A prospective randomized single-center pilot study. Transplantation 2006 : 81 : 1010 1015.
15. Weir ML. Methods for measurement of lymphocyte function. US Patent 5, 773, 232 : 1998.
16. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 2005 : 19 : 834 839.
17. Haigh TA, Lin X, Jia H, et al. EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines. J Immunol 2008 : 180 : 1643 1654.
18. Beckoff M, Kubo R, Grey H. Activation requirements for normal T cells: Accessory cell-dependent and -independent stimulation by anti-receptor antibodies. J Immunol 1986 : 137 : 1411 1419.
19. Bjercke S, Gaudernack G. Dendritic cells and monocytes as accessory cells in T-cell responses in man. I. Phenotypic analysis of dendritic cells and monocytes. Scand J Immunol 1985 : 21 : 493 500. (Pubitemid 15005717)
20. Halvorsen R, Leivestad T, Gaudernack G, Thorsby E. Role of accessory cells in the activation of pure T cells via the T cell receptor-CD3 complex or with phytohaemagglutinin. Scand J Immunol 1988 : 27 : 555 563.
21. Ojogho O, Ben-Youssef R, Franco E, Baron PW. The immune profile of pediatric kidney transplant recipients with dysfunctional allografts. Pediatr Transplant 2007 : 11 (Suppl. 1 1 124 (Abstract 240).
22. UNOS Data 2007. Pediatric kidney transplant recipients by gender. Available at: http://www.optn.org/latestData/rptData.asp.